Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cavenagh

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|December 24, 2015
Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignanciesK Yong, J Cavet, P Johnson, et al.
Bone Marrow Transplantation|April 3, 2001
Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusionL Silberstein, A Davies, S Kelsey, et al.
British Medical Journal|March 15, 1975
Letter: A new serviceR L Coppock, A J Cavenagh, K J Price, et al.
Psycho-Oncology|August 22, 2006
Mental health and other clinical correlates of euthanasia attitudes in an Australian outpatient cancer populationG L Carter, K A Clover, L Parkinson, et al.
International Journal of Laboratory Hematology|November 20, 2008
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myelomaF Davies, C Morris, J Bird, et al.
Blood Cancer Journal|July 26, 2012
Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomibT Ishii, T Seike, T Nakashima, et al.
Leukemia|September 20, 2011
Frequency of leukemic initiating cells does not depend on the xenotransplantation model usedJ Vargaftig, D C Taussig, E Griessinger, et al.
British Journal of Haematology|June 19, 2001
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patientsE Matutes, G P Taylor, J Cavenagh, et al.
Leukemia Research Reports|December 28, 2013
Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalitiesM Dennis, D Culligan, D Karamitros, et al.
British Journal of Cancer|September 6, 2017
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myelomaJ Cavenagh, H Oakervee, P Baetiong-Caguioa, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|December 24, 2015
Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignanciesK Yong, J Cavet, P Johnson, et al.
Bone Marrow Transplantation|April 3, 2001
Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusionL Silberstein, A Davies, S Kelsey, et al.
British Medical Journal|March 15, 1975
Letter: A new serviceR L Coppock, A J Cavenagh, K J Price, et al.
Psycho-Oncology|August 22, 2006
Mental health and other clinical correlates of euthanasia attitudes in an Australian outpatient cancer populationG L Carter, K A Clover, L Parkinson, et al.
International Journal of Laboratory Hematology|November 20, 2008
United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myelomaF Davies, C Morris, J Bird, et al.
Blood Cancer Journal|July 26, 2012
Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomibT Ishii, T Seike, T Nakashima, et al.
Leukemia|September 20, 2011
Frequency of leukemic initiating cells does not depend on the xenotransplantation model usedJ Vargaftig, D C Taussig, E Griessinger, et al.
British Journal of Haematology|June 19, 2001
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patientsE Matutes, G P Taylor, J Cavenagh, et al.
Leukemia Research Reports|December 28, 2013
Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalitiesM Dennis, D Culligan, D Karamitros, et al.
British Journal of Cancer|September 6, 2017
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myelomaJ Cavenagh, H Oakervee, P Baetiong-Caguioa, et al.
Pageof 5